Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

Despite the broader stock market's strong performance over the past few years, there are pockets of value where investors can still find good deals. Here are five rock-solid dividend stocks trading at ...

Buffett has taken a highly conservative approach to the stock market in recent years. However, he bought these three stocks ...

Beyond Meat's operating performance and corporate strategy have come into focus, which is bad news for investors.

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

For the second time in 18 months, Treace Medical Concepts Inc. disappointed investors by lowering its sales forecast. The ...

Purple Group, through the extraordinary rise of its EasyEquities platform, has seen its share price more than double in the ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, Nov. 13: Skillsoft ...